Chemours
447 hedge funds and large institutions have $2.89B invested in Chemours in 2026 Q1 according to their latest regulatory filings, with 81 funds opening new positions, 120 increasing their positions, 127 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 434 → 447 (+13)
6% less repeat investments, than reductions
Existing positions increased: 120 | Existing positions reduced: 127
2.4% less ownership
Funds ownership: 89.98% → 87.57% (-2.4%)
Holders
447
Holding in Top 10
10
Calls
$186M
Puts
$43.3M
Top Buyers
| 1 | +$64.2M | |
| 2 | +$34M | |
| 3 | +$25.4M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$21.8M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$16.7M |
Top Sellers
| 1 | -$60.7M | |
| 2 | -$56.2M | |
| 3 | -$33.4M | |
| 4 |
Millennium Management
New York
|
-$32.6M |
| 5 |
SCM
Scopia Capital Management
New York
|
-$22.8M |
